Levodopa/carbidopa: Phase I data

Top-line data from the open-label, crossover, U.K. Phase I ND0612-005 trial in 36 healthy volunteers showed that subcutaneous ND0612H achieved a “comparable” pharmacokinetic profile to that of intradu...